Related Experiment Video
Updated: Aug 10, 2026
08:07
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
Primary malignant tumors of the heart: four cardiovascular hormones decrease the number and DNA synthesis of human
Brian A Vesely1, Abdel Alli, Shijie Song
1Department of Biochemistry and Molecular Biology, University of South Florida Cardiac Hormone Center Tampa, FL 33612, USA.
Cardiology
|March 15, 2006
Summary
Four cardiovascular hormones, including vessel dilator and atrial natriuretic peptide, significantly reduced human angiosarcoma cell counts and DNA synthesis within 24 hours.
Area of Science:
- Cardiovascular Endocrinology
- Oncology
- Molecular Biology
Background:
- Investigated a family of six cardiovascular hormones for their anti-cancer effects.
- Focused on human angiosarcoma cells as the target for investigation.
Purpose of the Study:
- To determine the efficacy of specific cardiovascular hormones in reducing angiosarcoma cell proliferation.
- To elucidate the role of cyclic GMP in mediating these hormonal effects.
Main Methods:
- Treatment of human angiosarcoma cells with atrial natriuretic peptide, brain natriuretic peptide, C-natriuretic peptide, long acting natriuretic peptide, vessel dilator, and kaliuretic peptide.
- Quantification of cell number reduction and DNA synthesis inhibition.
- Detection of natriuretic peptide receptor C expression.
Main Results:
- Vessel dilator, long acting natriuretic peptide, kaliuretic peptide, and atrial natriuretic peptide decreased angiosarcoma cell count by 29-61% and DNA synthesis by 68-85% within 24 hours.
- Cyclic GMP was identified as an intracellular mediator for these effects.
- Brain natriuretic peptide and C-natriuretic peptide showed no significant impact on cell proliferation.
Conclusions:
- Four cardiovascular hormones demonstrate potent anti-proliferative effects on human angiosarcoma cells.
- Inhibition of DNA synthesis, partly mediated by cyclic GMP, is the primary mechanism of action.
- These findings suggest potential therapeutic applications for cardiovascular hormones in angiosarcoma treatment.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:10Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...